We are live on ! Find out more
BLFS icon

BioLife Solutions

17 hedge funds and large institutions have $609K invested in BioLife Solutions in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

6% more funds holding

Funds holding: 1617 (+1)

7% less capital invested

Capital invested by funds: $653K → $609K (-$44K)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

BLFS Hedge Fund Activity: Q2 2016 in Review

17 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2016, worth a combined $609K — down 6.7% from $653K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BLFS positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 0 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $22.5K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $2K sold.

  • 17 institutional investors held BioLife Solutions (BLFS) as of Q2 2016, up from 16 in Q1 2016.
  • Funds reported $609K of BioLife Solutions stock for Q2 2016, down 6.7% quarter-over-quarter.
  • 4 funds opened new BioLife Solutions positions in Q2 2016 and 3 closed out, a net change of +1 holder.
  • The largest BioLife Solutions buyer in Q2 2016 was Two Sigma Securities, an estimated $22.5K added.
  • The largest BioLife Solutions seller in Q2 2016 was Tower Research Capital (TRC), an estimated $2K sold.

Based on aggregated 13F filings for Q2 2016.